Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
8 studies found for:    21670242 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Women's INternational Transcatheter Aortic Valve Implantation Registry
Condition: Symptomatic Aortic Stenosis
Intervention:
2 Recruiting Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
Condition: ST-segment Elevation Myocardial Infarction
Interventions: Drug: alteplase;   Drug: Placebo
3 Not yet recruiting A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure
Conditions: Non-Valvular Atrial Fibrillation;   Left Atrial Appendage Closure
Interventions: Drug: Edoxaban;   Device: WATCHMAN LAA Closure;   Drug: Aspirin and Clopidogrel;   Drug: Aspirin and Warfarin
4 Recruiting A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI
Condition: Aortic Valve Stenosis
Interventions: Drug: Ticagrelor plus ASA;   Drug: Clopidogrel plus ASA
5 Recruiting Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
Conditions: Cardiovascular Disease;   Interventional Cardiology
Interventions: Drug: Aspirin;   Drug: Placebo;   Drug: ticagrelor
6 Terminated Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day Discharge
Condition: Coronary Artery Disease
Intervention: Procedure: Same day discharge
7 Unknown  Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
Condition: Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: clopidogrel;   Drug: Aspirin;   Procedure: PCI
8 Completed Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation
Condition: Coronary Artery Disease
Intervention: Device: Qvanteq bioactive coronary stent

Study has passed its completion date and status has not been verified in more than two years.